AI assistant
VECTION TECHNOLOGIES LTD — Share Issue/Capital Change 2025
Jan 16, 2025
66017_rns_2025-01-16_ed8a3c2c-6a37-4a44-9846-e267b26ab981.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
VECTION TECHNOLOGIES LTD
Announcement Type
New announcement
Date of this announcement
Friday January 17, 2025
The +securities to be quoted are: Other
Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.
Securities listed on Appendix 3B dated 28/08/24. Issue in consideration for acquisition of Generative AI business TDB.
Total number of +securities to be quoted
| ASX +security | Number of +securities to | ||
|---|---|---|---|
| code | Security description | be quoted | Issue date |
| VR1 | ORDINARY FULLY PAID | 143,175,278 | 16/01/2025 |
Refer to next page for full details of the announcement
Appendix 2A - Application for quotation of securities
1 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of entity
VECTION TECHNOLOGIES LTD
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type
Registration number
ABN 93614814041
1.3 ASX issuer code
VR1
1.4 The announcement is
New announcement
1.5 Date of this announcement
17/1/2025
Appendix 2A - Application for quotation of securities
2 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
Other
Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.
2.2 The +class of +securities to be quoted is:
Additional +securities in a class that is already quoted on ASX ("existing class")
2.3c Have these +securities been offered under a +disclosure document or +PDS?
No
2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
Securities listed on Appendix 3B dated 28/08/24. Issue in consideration for acquisition of Generative AI business TDB.
2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:
Not applicable - the entity has arrangements in place with the holder that ensure the securities cannot be on-sold within 12 months in a manner that would breach section 707(3) or 1012C(6)
Appendix 2A - Application for quotation of securities
3 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Additional +securities to be quoted in an existing class ASX +security code and description VR1 : ORDINARY FULLY PAID Issue date 16/1/2025 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 143,175,278 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities Acquisition of the issued capital of TDB Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.010000 Any other information the entity wishes to provide about the +securities to be quoted Fully paid shares issued as consideration for the acquisition of TDB. Approved by shareholders on 28 October 2024. The purpose(s) for which the entity is issuing the securities To pay for the acquisition of an asset Please provide additional details Generative AI business TDB per the announcements of 29 August 2024.
Appendix 2A - Application for quotation of securities
4 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)
+securities subject of this application) |
|
|---|---|
| Total number of | |
| ASX +security code and description | +securities on issue |
| VR1 : ORDINARY FULLY PAID | 1,493,656,123 |
| VR1O : OPTION EXPIRING 11-NOV-2027 | 270,000,000 |
| 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) | |
| Total number of | |
| ASX +security code and description | +securities on issue |
| VR1AA : PERFORMANCE RIGHTS | 23,295,612 |
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
Appendix 2A - Application for quotation of securities
5 / 6
Appendix 2A - Application for quotation of securities
==> picture [21 x 22] intentionally omitted <==
Part 5 - Other Listing Rule requirements
5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No
5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes
5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1
28/10/2024
Appendix 2A - Application for quotation of securities
6 / 6